Repaglinide tablets 0.25 mg “Sawai” is a generic formulation by Sawai Pharmaceutical containing Repaglinide, a meglitinide for type 2 diabetes. This rapid-acting insulin secretagogue helps control postprandial blood glucose, and is a 0.25 mg 1 tablet with YJ code 3969013F1038.
Repaglinide tablets 0.25 mg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
